Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematology
•
Transplant nephrology
What is your approach to post kidney transplant erythrocytosis if a patient is already on an ACEi and is asymptomatic but with a Hb that is consistently >18?
Related Questions
Would you consider pursuing renal transplantation in a patient with multiple myeloma?
Does ASC4FIRST data justify the use of first-line asciminib for all newly diagnosed CML over other TKIs, considering that post-progression survival data is not yet mature?
How do you manage ocular hemorrhages while on acalabrutinib for CLL?
Would you consider initiating eculizumab without plasmapheresis as initial therapy for a patient with renal TMA who has a low suspicion of TTP based on a scoring algorithm?
How would you treat progressive Rosai Dorfman Destombes disease after initial limited radiation therapy?
How do you approach delivery planning in patients with T1 vWD?
Would you expect a reduced neutrophil count in individuals with a partial duffy null phenotype?
What is your approach to the management of unprovoked distal DVTs?
When, if ever, would you recommend the co-administration of oral anticoagulants with NSAIDS?
Would you supplement iron for low iron studies in absence of anemia?